Contact Us

AbbVie

Hagaplan 4, SE-113 68 Stockholm, Sverige

+46 (0)8 684 44 600

info@abbvie.se

SKINVIVE™ by JUVÉDERM® is a medical device Class III CE0344. Manufactured by Pringy, France. SKINVIVE™ by JUVÉDERM® is an injectable implant used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity1.  

This product is contraindicated for patients with severe allergies or allergies to gram-positive bacterial proteins or lidocaine and for women who are pregnant or breastfeeding. 

The most common side effects include temporary reactions at the treatment site such as swelling, non-inflammatory nodule, inflammatory reaction, herpes virus reactivation, allergic reaction, hematomas, pain/tenderness, redness, and discoloration. 

Other side effects can occur such as unsatisfactory results after treatment, device migration, inflammatory nodule, cyst, tissue damage, necrosis, infection, autoimmune disorder, vision disorder/loss, vascular occlusion, stroke, neurological symptoms and cardiac complications.  

Medical devices have associated risks, please refer to the contraindications, warnings and precautions sections in the Instructions For Use. 

  1. SKINVIVE™ by JUVÉDERM® IFU. 20089472. Revision 2024-11-25. 

This content is intended for adult (>18yrs) audience only. You should always consult a healthcare professional to help you decide if SKINVIVE by Juvéderm is right for you and provide you with a full list of side effects.